News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

One-off prison-based HCV screening cost-effective, reduces cirrhosis, HCC, and HCV-related mortality
07 May 2026
byNatalia Reoutova
A University of Hong Kong analysis shows one-off hepatitis C virus (HCV) screening of persons in custody (PICs) to be cost-effective and reduce the rates of HCV-related compensated and decompensated cirrhosis (DC), hepatocellular carcinoma (HCC), and HCV-related mortality.
One-off prison-based HCV screening cost-effective, reduces cirrhosis, HCC, and HCV-related mortality
07 May 2026
Enzalutamide plus leuprolide delays metastasis, progression in prostate cancer
06 May 2026
byStephen Padilla
Prostate cancer patients treated with enzalutamide plus leuprolide have a higher probability of remaining free of distant metastasis, castration resistance, symptomatic progression, and first symptomatic skeletal event (SSE) at 5 years than those treated with leuprolide alone, as shown by the results of the EMBARK study.







